Technology Jun 18, 2021 05:26 PM (GMT+8) · EqualOcean
Fosun medicine announced that its subsidiary, fuchuang medicine, has received the approval from the State Drug Administration for the clinical trial of fcn-098 capsule for the treatment of advanced malignant tumor; The phase I clinical trial of the new drug will be carried out in China (excluding Hong Kong, Macao and Taiwan) when the conditions are met.
Related companies: